Our colleagues, Tony Bou Kheir, Head of Analytical Development and Quality Control, and Xiangyi Jing, Senior Analytical Scientist, will be in London, UK from today, 22 May, until 24 May to take part in the 5th Annual Gene Therapy Analytical Development Europe #Conference. They will participate in a variety of panels and presentations, including: 🔬Panel Discussion, including insights from Tony and other #LifeSciences industry leaders: ‘Discussing Strategies to Correlate the Outputs of a Potency Matrix Approach to Manage Regulatory Expectations’ from 13:00-14:00BST on 22 May 🧬Presentation of new data from Jing: ‘Utilising HPLC for Analysis of Aggregation & to Enhance Separation Resolution Between Empty, Full & Partial Capsids’ from 12:00-12:30BST on 24 May 🧪Presentation of new data from Tony: ‘Evaluating Best Practice for Analytical Technology Transfer Process to Ensure Smooth Transitions During Upscaling’ from 15:30-16:00BST on 24 May Please stop by if you are also attending, or reach out to Tony or Jing if you want to learn more about our novel AAV #GeneTherapy approach. #Biotech #People #Innovation #KidneyDisease
I’m thrilled to be presenting at the Gene Therapy Analytical Development conference in London this week. Be sure to check out my presentation and comment or reach out to me if you have any questions. I hope to see you there! WEBSITE: https://ter.li/n8axmn REGISTRATION: https://ter.li/n8axmn
